JPRN-UMIN000008025招募中未知
Safety Research of administration of DTP, PCV7, Hib Vaccines to Infants at NICU - Safety Research of administration of DTP, PCV7, Hib Vaccines to Infants at NIC
Tokyo Metropolitan Children's Medical Center0 个研究点目标入组 200 人开始时间: 2012年5月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 8weeks-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Previous history of vaccinations Acute illness such as acute infection, acute metabolic disorder, acute renal disorder, acute cardiac disorder, acute neurological disorder and acuter respiratory disorder 13 trisomy and 18 trisomy including mosaic Patients who were considered as inappropriate to participate in this study by responsible physicians
研究者
相似试验
未知
1 期
DS-7250 -Evaluation of Safety, Pharmacokinetics, and Pharmacodynamics After Multiple Oral Administration in Patients With Type 2 DiabetesType 2 Diabetes MellitusJPRN-jRCT2080221918DAIICHISANKYO Co.,Ltd.
进行中（未招募）
不适用
Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in ChinaHealthy volunteers: active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive infections caused by Haemophilus influenzae type b (such as meningitis, septicaemia, cellulitis, arthritis, epiglottitis, pneumopathy, osteomyelitis)MedDRA version: 18.1Level: LLTClassification code 10036897Term: Prophylactic vaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 18.1Level: HLGTClassification code 10043413Term: Therapeutic procedures and supportive care NECSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 18.1Level: PTClassification code 10021430Term: ImmunisationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 18.1Level: HLTClassification code 10021431Term: ImmunisationsSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2015-005404-29-Outside-EU/EEASANOFI PASTEUR SA900
尚未招募
1 期
Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315Healthy VolunteersNCT06592495Daewoong Pharmaceutical Co. LTD.52
进行中（未招募）
不适用
Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 MonthsHealthy volunteers: active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive infections caused by Haemophilus influenzae type b (such as meningitis, septicaemia, cellulitis, arthritis, epiglottitis, pneumopathy, osteomyelitis)MedDRA version: 18.1Level: LLTClassification code 10036897Term: Prophylactic vaccinationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 18.1Level: HLGTClassification code 10043413Term: Therapeutic procedures and supportive care NECSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 18.1Level: PTClassification code 10021430Term: ImmunisationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 18.1Level: HLTClassification code 10021431Term: ImmunisationsSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2015-005353-12-Outside-EU/EEASANOFI PASTEUR SA792
招募中
1 期
RC48-ADC Combined With Radiotherapy in the Treatment of Locally Advanced Solid Tumors With HER2 ExpressionSolid TumorNCT05940896RemeGen Co., Ltd.24